Eugene W. Gerner

Dr. Gerner is the founding Director of the Gastrointestinal Cancer Program at the Arizona Cancer Center and the founding Principal Investigator of one of five current NIH-funded Specialized Programs of Research Excellence (SPOREs) in gastrointestinal cancer. He is a fully tenured Professor on the faculty of the University of Arizona College of Medicine where he has worked over the last 30 years. In addition to founding CPP, Dr. Gerner also led an NIH-funded cancer therapeutics development program in experimental radiation oncology from 1977 to 1990, which was part of the first approval by the US Food and Drug Administration for technology producing hyperthermia for cancer treatment. He also spent a sabbatical year at the Merrell Dow Research Institute working with scientists who developed CPP-1X and other inhibitors of the polyamine pathway to treat/prevent cancer and other diseases affecting humans. Dr. Eugene Gerner graduated from the University of Wisconsin at Madison with a Bachelor of Art (Physics) and a Master of Science (Physics) in 1969 and 1970, respectively. He received a Ph.D. degree in biophysics from the University of Texas Graduate School of Biomedical Sciences (GSBS) in Houston in 1974.